Synaptogenix Statistics

Total Valuation

Synaptogenix has a market cap or net worth of $3.72 million. The enterprise value is -$11.12 million.

Market Cap	3.72M
Enterprise Value	-11.12M

Important Dates

The last earnings date was Thursday, May 15, 2025, after market close.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

Synaptogenix has 1.39 million shares outstanding. The number of shares has increased by 103.15% in one year.

Current Share Class	1.39M
Shares Outstanding	1.39M
Shares Change (YoY)	+103.15%
Shares Change (QoQ)	+2.62%
Owned by Insiders (%)	0.66%
Owned by Institutions (%)	7.41%
Float	1.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.72
P/TBV Ratio	0.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 72.71

Current Ratio	72.71
Quick Ratio	70.41
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -83.05% and return on invested capital (ROIC) is -26.38%.

Return on Equity (ROE)	-83.05%
Return on Assets (ROA)	-17.29%
Return on Invested Capital (ROIC)	-26.38%
Return on Capital Employed (ROCE)	-40.93%
Revenue Per Employee	n/a
Profits Per Employee	-$3.24M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.32% in the last 52 weeks. The beta is 1.29, so Synaptogenix's price volatility has been higher than the market average.

Beta (5Y)	1.29
52-Week Price Change	-41.32%
50-Day Moving Average	2.34
200-Day Moving Average	2.91
Relative Strength Index (RSI)	61.30
Average Volume (20 Days)	14,367

Short Selling Information

The latest short interest is 4,335, so 0.31% of the outstanding shares have been sold short.

Short Interest	4,335
Short Previous Month	4,892
Short % of Shares Out	0.31%
Short % of Float	0.31%
Short Ratio (days to cover)	0.64

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-6.19M
Pretax Income	-4.53M
Net Income	-12.97M
EBITDA	-6.18M
EBIT	-6.19M
Earnings Per Share (EPS)	-$9.90

Full Income Statement

Balance Sheet

The company has $14.83 million in cash and n/a in debt, giving a net cash position of $14.83 million or $10.67 per share.

Cash & Cash Equivalents	14.83M
Total Debt	n/a
Net Cash	14.83M
Net Cash Per Share	$10.67
Equity (Book Value)	6.45M
Book Value Per Share	3.72
Working Capital	15.11M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-5.05M
Capital Expenditures	n/a
Free Cash Flow	-5.05M
FCF Per Share	-$3.64

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Synaptogenix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-103.15%
Shareholder Yield	-103.15%
Earnings Yield	-348.74%
FCF Yield	-135.92%

Analyst Forecast

The average price target for Synaptogenix is $14.00, which is 423.36% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.00
Price Target Difference	423.36%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 5, 2024. It was a reverse split with a ratio of 0.04:1.

Last Split Date	Apr 5, 2024
Split Type	Reverse
Split Ratio	0.04:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2